Atossa Therapeutics Inc (NASDAQ:ATOS)

1.55
Delayed Data
As of 11:31am ET
 +0.0398 / +2.64%
Today’s Change
1.19
Today|||52-Week Range
7.39
-1.29%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +158.10% increase from the last price of 1.55.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since December, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
$0.00
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
Growthannually 47.64%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.